Kirking D M, Ascione F J, Richards J W
Department of Health Services Management and Policy, School of Public Health, University of Michigan, Ann Arbor 48109-2029.
Milbank Q. 1990;68(1):29-51.
Pharmaceutical price increases and greater coverage of outpatient prescription medications have stimulated interest in containing drug benefit-program costs. While mail pharmacy services (MPS) may achieve savings through volume purchasing, high usage of generic drugs, and dispensing larger quantities of medication per prescription, efforts are also underway to adapt community-pharmacy-based services to keep costs down in these areas. No controlled studies document a difference in quality between the two types of services. Third-party administrators and benefit managers need to consider factors such as providing information to patients, monitoring drug therapy, dispensing patients' correct medication, and cost-control incentives when assessing MPS's role in prescription drug programs.
药品价格上涨以及门诊处方药覆盖范围的扩大引发了人们对控制药品福利计划成本的关注。虽然邮购药房服务（MPS）可能通过批量采购、高比例使用非专利药以及每张处方配药量更大来实现成本节约，但人们也在努力调整基于社区药房的服务，以在这些方面降低成本。尚无对照研究证明这两种服务在质量上存在差异。第三方管理机构和福利管理者在评估MPS在处方药计划中的作用时，需要考虑向患者提供信息、监测药物治疗、为患者配准正确药物以及成本控制激励措施等因素。
